July 31, 2019
Hello Heart, maker of a digital chronic disease health program for employees, has raised $12 million in Series B funding. The round was led by Khosla Ventures, with additional support from previous backers BlueRun Ventures, Maven Ventures and Resolute Ventures.
WHAT THEY DO
Hello Heart’s bread and butter is its app-driven platform for hypertension, blood pressure and general cardiovascular health...
July 29, 2019
After much speculation and anticipation, chronic care management startup Livongo officially went public on Thursday. The company closed its first day 36% above its initial pricing of $28 and is currently trading for over $41 per share on NASDAQ. The company's includes more than 12 million shares of common stock.
“It’s a signal to the market ... that [the industry] is ready for a consumer-first...
June 28, 2019
Months after the first rumors began to swirl, chronic disease management startup Livongo Health has officially filed for an IPO on the Nasdaq Global Select Market.
The company has not yet determined a price range or the number of shares going on offer. Morgan Stanley & Co., Goldman Sachs & Co. and JP Morgan Securities will serve as the lead book runners.
Sources close to Livongo told...
June 26, 2019
Digital chronic disease management startup Livongo is making the jump from patients’ pockets to their wrists with new integrations that will bring some of the mobile app’s alerts and features to consumer smartwatches.
Starting today, certain models of Apple Watches, Fitbits and Samsung Gear wearables will surface individualized “Health Nudges” that encourage the wearer to perform certain...
June 26, 2019
San Francisco-based digital chronic disease management company Omada Health has closed a $73 million funding round led by Wellington Management Company. Cigna Ventures, Andreessen Horowitz, U.S. Venture Partners, Norwest Venture Partners, Kaiser Permanente Ventures, Sanofi Ventures, Civilization Ventures and Providence Ventures also contributed.
WHAT THEY DO
Omada offers a slew of digital...
June 6, 2019
About the Author: Dr. Daniel Yazdi is an Internal Medicine Resident at Brigham and Women’s Hospital/Harvard Medical School interested in the intersection of digital health and clinical medicine. He can be followed on Twitter @DanielYazdi.
Medicine is reaching a problem of epic proportions: without any changes to how primary care is delivered, in 2030 there will be a projected deficit of 14,800 to...
May 15, 2019
Solera Health, a digital marketplace for benefit and chronic disease management programs, has raised $42 million in a Series C round led by Health Care Service Corporation subsidy HCSC Ventures. Prior backers BlueCross BlueShield Venture Partners/Sandbox Advantage Fund, Adams Street Partners and SJF Ventures participated as well.
WHAT THEY DO
Solera’s platform hosts a broad selection of digital...
March 18, 2019
At the American College of Cardiology this past weekend, chronic disease management platform Livongo reported on six-month results from its first major study of its hypertension management platform, which is already in use with many of its customers.
The study looked at 708 individuals with both diabetes and hypertension. Patients whose blood pressure was higher than 130/80 mm Hg saw their...
March 7, 2019
It's been a while since the digital health space has seen an IPO. But that's about to change, according to The Wall Street Journal, which reports that chronic disease management startup Livongo Health is planning to go public this year.
According to the Journal, the company has hired Morgan Stanley, Goldman Sachs and JPMorgan Chase as underwriters, and is looking towards a valuation over $1...
January 31, 2019
This morning diabetes self-management company One Drop announced its platform’s integration with Apple’s Health Records. As part of the integration patients who use the One Drop | Experts are able to share their EHRs with their personal diabetes coach. This gives patients the ability to share their vitals, lab results and medication history with One Drop coaches.
This news coincides with the...